Priya Menon | CureTalks
Priya is Host and Scientific Media Editor at CureTalks/TrialX, an internet radio talk show on healthcare which brings together experts, patients, advocates on the same platform engaging in ‘Discussions for Solutions’. Priya bridges the gap between research and information through her discussions on CureTalks with eminent guests from across the globe. Her interest in communication of science has encouraged her to write extensively presenting a varied view on healthcare and associated domains. Priya is a masters in Microbiology. She also holds degrees in Patent Law, Media Law, and certifications in Writing in Sciences from Stanford University and Management from IIM Bangalore, India. She is also a guest columnist at The Week. Follow (@Cure_talk).
Related Talks
In a Race to Cure HIV : Gene Therapy, Vaccines and Other Approaches
Progress in antiretroviral therapy has considerably reduced mortality and notably improved the quality of life of individuals infected with HIV . However, drug…
Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma.…
Lung Cancer Mutations and Treatment Advances
Lung cancer, the most common cancer type with the highest mortality, can largely be categorized by the genetic mutations that cause it. By…
Goals and challenges of developing a patient focused myeloma center of excellence
The multiple myeloma treatment field has undergone several changes over the past 10-20 years. The average overall survival has changed from 1-3 years…
CRISPR-edited Immune Cells Enhance Fight Against Blood Cancers
The Nobel prize winning CRISPR-Cas9 genome editing system is being explored for its potential use in cancer research and treatment. By deleting, inactivating,…